Aytu Biopharma AYTU
NASDAQ AYTU
$2.16 -0.03 (-1.37%)
As of: Sep 9, 2026 · 1:25 PM EDT

Aytu Biopharma (AYTU) EPS (Diluted) (2020 - 2026)

Analysis

Aytu Biopharma (AYTU) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 2.27
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 2.04
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn -0.54
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 1.67
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -0.04
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 0.33
7 Revolution Medicines 44.19 Bn 44.19 Bn - -3.06
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 2.81
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 7.27
10 Aytu Biopharma 22.71 Mn -4.01 Mn 7.60 Mn -0.53
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.53
Dec 31, 2025 -1.05
Sep 30, 2025 0.10
Jun 30, 2025 -2.01
Mar 31, 2025 0.49
Dec 31, 2024 0.09
Sep 30, 2024 0.16
Jun 30, 2024 -0.05
Mar 31, 2024 -0.52
Dec 31, 2023 -0.04
Sep 30, 2023 -1.48
Jun 30, 2023 0.34
Mar 31, 2023 -1.93
Dec 31, 2022 -2.15
Sep 30, 2022 -0.28
Jun 30, 2022 4.74
Mar 31, 2022 -35.90
Dec 31, 2021 -8.74
Sep 30, 2021 -21.76
Jun 30, 2021 -22.38